Group 1 - The company, Yidu Tech (02158), announced a share buyback on January 28, repurchasing 204,000 shares at approximately HKD 6 per share, totaling around HKD 1.23 million [1] - This marks the third consecutive trading day of intensive buyback operations, with a total of approximately 709,000 shares repurchased and over HKD 4.2 million spent, demonstrating the company's confidence in its intrinsic value and long-term development [1] - The company's main business has also shown progress, with the number of insured individuals in the 2026 Beijing Universal Health Insurance project exceeding 4.5 million, highlighting its operational strength and market recognition [1] Group 2 - The founder and chairman of the company, Gong Rujing, was recently invited to attend the 2026 Winter Davos Forum, where a collaboration was announced between the Novartis Foundation, the Brunei Ministry of Health, and the company's subsidiary, EVYD, to implement a data-driven cardiovascular disease prevention project called CARDIO4Cities, expanding its international cooperation [1] - The company was ranked first in the authoritative list of the "2025 Medical Big Data Companies," marking its seventh consecutive year at the top, showcasing its strong technical foundation, mature product system, and extensive industry experience [1]
医渡科技(02158)连续三日回购超420万港元，主运营的北京普惠健康保参保突破450万